Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Saint John's Cancer Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pembrolizumab and Pemetrexed for Progressive Chordoma

Phase 2

Recruiting

Conditions: Chordomas
Chordoma

Interventions: Drug: Pembrolizumab
Drug: Pemetrexed Phase 2

First Posted Date: 2025-01-27

Last Posted Date: 2025-01-27

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 21

Registration Number: NCT06794645

Locations: 🇺🇸
Providence Saint John's Health Center, Santa Monica, California, United States

Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.

Not Applicable

Recruiting

Conditions: IORT-Intra-Operative Radiation Therapy

First Posted Date: 2022-03-21

Last Posted Date: 2023-04-11

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 30

Registration Number: NCT05289466

Locations: 🇺🇸
Providence Saint John's Hospital, Santa Monica, California, United States

Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

Recruiting

Conditions: Early-stage Breast Cancer
Breast Carcinoma in Situ
Breast Neoplasms

First Posted Date: 2020-10-26

Last Posted Date: 2024-04-16

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 1000

Registration Number: NCT04603209

Locations: 🇺🇸
John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, California, United States

The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition

Not Applicable

Completed

Conditions: Alzheimer Disease
Mild Cognitive Impairment

First Posted Date: 2019-09-09

Last Posted Date: 2025-05-15

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 97

Registration Number: NCT04082611

Locations: 🇺🇸
Pacific Brain Health Center, Santa Monica, California, United States

Pemetrexed for the Treatment of Chordoma

Phase 1

Completed

Conditions: Chordoma

Interventions: Drug: Pemetrexed

First Posted Date: 2019-05-17

Last Posted Date: 2023-03-07

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 15

Registration Number: NCT03955042

Locations: 🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States

Memantine XR and Pregabalin for Chemotherapy-Induced Peripheral Neuropathy

Completed

Conditions: Chemotherapy-induced Peripheral Neuropathy

Interventions: Drug: Memantine XR-pregabalin combination therapy

First Posted Date: 2018-10-17

Last Posted Date: 2022-04-06

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 20

Registration Number: NCT03709888

Locations: 🇺🇸
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States

A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer

Phase 1

Completed

Conditions: Newly Diagnosed High Grade Glioma

Interventions: Drug: Nivolumab monotherapy
Drug: Temozolomide
Drug: Nivolumab
Radiation: conformal brain radiation therapy
Drug: Ipilimumab
Drug: 5-day Temozolomide
Drug: Bevacizumab
Drug: Lomustine

First Posted Date: 2018-02-07

Last Posted Date: 2023-11-08

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 49

Registration Number: NCT03425292

Locations: 🇺🇸
Saint John's Cancer Institute, Santa Monica, California, United States

CancerLife: Patient-Driven Solution in Cancer Care

Not Applicable

Completed

Conditions: Cancer

First Posted Date: 2017-12-13

Last Posted Date: 2021-02-09

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 30

Registration Number: NCT03371147

Locations: 🇺🇸
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States

Mitigating Cephalad Fluid Shifts: A NSBRI Study

Not Applicable

Completed

Conditions: Intracranial Pressure

First Posted Date: 2017-03-31

Last Posted Date: 2017-08-16

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 3

Registration Number: NCT03097523

Locations: 🇺🇸
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States

Evaluation of a Mobile Digital Solution for Cancer Care and Research

Not Applicable

Completed

Conditions: Cancer
Caregivers
Quality of Life

First Posted Date: 2017-03-29

Last Posted Date: 2021-02-09

Lead Sponsor: Saint John's Cancer Institute

Target Recruit Count: 30

Registration Number: NCT03094741

Locations: 🇺🇸
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy